“Opioid abuse, misuse, and addiction has become one of the most profound public health crises facing the U.S. today,” says Jeffrey Shuren, FDA, CDRH. The agency, along with many others, are scrambling to find ways to confront the crisis.

One challenge is the ability to quickly identify and quantify opioid drugs — an issue that is of great importance in the face of this ongoing opioid epidemic in the United States. Yet techniques for trace analysis of opioids, particularly for fentanyl, an extremely potent synthetic drug of abuse and the main driver of the current wave of opioid crisis, are often not readily accessible.

Researchers have developed a fast, sensitive, and quantitative technique, with excellent portability, for opioids analysis. This breakthrough technique can potentially offer crucial information for drug control officials and also for health professionals and/or communities on the frontlines of this crisis.

In an upcoming webinar , the researchers will discuss this new tool —a portable Raman approach created by pairing an easy-to-perform procedure with a compact Raman spectrometer suitable for rapid, on-site identification and quantification for trace fentanyl analysis.

The webinar will explain how the fentanyl spiked in urine was detected at concentrations as low as several nanograms per milliliter. The portable surface‐enhanced Raman scattering (SERS) also allows detection of trace fentanyl laced in recreational drugs at mass concentrations as low as 0.05 percent in other common opioid drugs.

Click here to register for the webinar.